Latest Breaking News On - Accordion pill - Page 1 : comparemela.com

Health your username 6 days ago A stockholder is suing Intec Pharma Ltd., Intec’s board of directors, and related entities over alleged violations of the Securities Exchange Act, per a Friday complaint filed in the District of Delaware regarding a proposed merger. Plaintiff Craig Davidson is an owner of common stock of Intec, a biopharmaceutical company developing drug products based on its Accordion Pill platform that seeks to “improve the efficacy and safety” of drug products. On March 15, Intec’s board of directors executed a merger agreement with Intec Parent, Inc., Dillion Merger Subsidiary Inc., Domestication Merger Sub Ltd., and Decoy Biosystems Inc. The companies said in a news release that they are aiming for the merger to be executed in the third quarter of 2021, the complaint detailed. A registration statement with the Securities and Exchange Commission (SEC) followed on April 20.

United statesCraig davidsonExchange commissionIntec parent incDillion merger subsidiary incIntec pharma ltdDomestication merger sub ltdSecurities exchangeDecoy biosystems incSecurities exchange actAccordion pillIntec parentDecoy biosystemsRegistration statementஒன்றுபட்டது மாநிலங்களில்கிரேக் டேவிட்சன்